Recap: CytomX Therapeutics Q4 Earnings

CytomX Therapeutics CTMX reported its Q4 earnings results on Monday, March 11, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

CytomX Therapeutics beat estimated earnings by 133.0%, reporting an EPS of $0.01 versus an estimate of $-0.03.

Revenue was up $25.66 million from the same period last year.

Last quarter the company beat on EPS by $0.23 which was followed by a 2.0% drop in the share price the next day.

Here's a look at CytomX Therapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.19	-0.20	-0.11	-0.24
EPS Actual	0.04	-0.02	-0.05	-0.42
Revenue Estimate	14.14M	13.88M	19.59M	17.85M
Revenue Actual	26.38M	24.72M	23.50M	946K

To track all earnings releases for CytomX Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar